Brandy Wilkinson

Brandy Wilkinson has over a decade of work experience in the pharmaceutical, biotech, and research industry. Brandy is currently the Chief Executive Officer at GemPharmatech. Prior to this, Brandy served as the SVP, Scientific Solutions at Innovive from 2022 to 2023. Brandy also held the position of Vice President, Operations and Research at Explora BioLabs from 2019 to 2022. In this role, they had direct management and oversight of various business units and was responsible for the design and opening of multiple vivarium facilities. Before that, Brandy worked at Covance as a Principal Scientist/ Manager In Vivo Pharmacology - Oncology and as a Senior Scientist/Manager Preclinical Oncology. Brandy also has experience at Champions Oncology, Inc. as the Director of Translational Oncology Services and at The Jackson Laboratory, where they held various positions including Study Director In Vivo Pharmacology-Oncology and Technical Information Scientist. Overall, Brandy has extensive experience in preclinical mouse models of cancer, oncology research, and scientific leadership.

Brandy Wilkinson received a BA in Psychology from Coe College in 1997. Later, they pursued a Ph.D. in Neuroscience at Florida State University from 1997 to 2002. Following that, they engaged in Postdoctoral Training in Neuroscience at Case Western Reserve University from 2002 to 2008. In 2015, they acquired an Executive Certificate in the Business of Life Science from Indiana University - Kelley School of Business.